ArticleFrontiers in oncology2021

Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification.

Yanyang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.